Randomized Clinical Trials in Hepatocellular Carcinoma

Adam C. Yopp, William R. Jarnagin

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Hepatocellular carcinoma is among the most common solid tumors, ranking behind only lung and gastric for cancer-related deaths worldwide. Despite improved surveillance programs in many countries, most patients present with advanced-stage cancer and chronic hepatic dysfunction limiting the available treatment options. This article reviews the most pertinent randomized controlled trials with respect to surgical and adjuvant interventions that shape the current treatment algorithm for hepatocellular carcinoma.

Original languageEnglish (US)
Pages (from-to)151-162
Number of pages12
JournalSurgical Oncology Clinics of North America
Volume19
Issue number1
DOIs
StatePublished - Jan 2010

Fingerprint

Hepatocellular Carcinoma
Randomized Controlled Trials
Liver Neoplasms
Stomach Neoplasms
Lung Neoplasms
Therapeutics
Neoplasms

Keywords

  • Evidence-based medicine
  • Hepatocellular carcinoma
  • Management
  • Randomized controlled trials

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Randomized Clinical Trials in Hepatocellular Carcinoma. / Yopp, Adam C.; Jarnagin, William R.

In: Surgical Oncology Clinics of North America, Vol. 19, No. 1, 01.2010, p. 151-162.

Research output: Contribution to journalArticle

@article{c1ee82ace2c24d14817534978fd9479d,
title = "Randomized Clinical Trials in Hepatocellular Carcinoma",
abstract = "Hepatocellular carcinoma is among the most common solid tumors, ranking behind only lung and gastric for cancer-related deaths worldwide. Despite improved surveillance programs in many countries, most patients present with advanced-stage cancer and chronic hepatic dysfunction limiting the available treatment options. This article reviews the most pertinent randomized controlled trials with respect to surgical and adjuvant interventions that shape the current treatment algorithm for hepatocellular carcinoma.",
keywords = "Evidence-based medicine, Hepatocellular carcinoma, Management, Randomized controlled trials",
author = "Yopp, {Adam C.} and Jarnagin, {William R.}",
year = "2010",
month = "1",
doi = "10.1016/j.soc.2009.09.012",
language = "English (US)",
volume = "19",
pages = "151--162",
journal = "Surgical Oncology Clinics of North America",
issn = "1055-3207",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Randomized Clinical Trials in Hepatocellular Carcinoma

AU - Yopp, Adam C.

AU - Jarnagin, William R.

PY - 2010/1

Y1 - 2010/1

N2 - Hepatocellular carcinoma is among the most common solid tumors, ranking behind only lung and gastric for cancer-related deaths worldwide. Despite improved surveillance programs in many countries, most patients present with advanced-stage cancer and chronic hepatic dysfunction limiting the available treatment options. This article reviews the most pertinent randomized controlled trials with respect to surgical and adjuvant interventions that shape the current treatment algorithm for hepatocellular carcinoma.

AB - Hepatocellular carcinoma is among the most common solid tumors, ranking behind only lung and gastric for cancer-related deaths worldwide. Despite improved surveillance programs in many countries, most patients present with advanced-stage cancer and chronic hepatic dysfunction limiting the available treatment options. This article reviews the most pertinent randomized controlled trials with respect to surgical and adjuvant interventions that shape the current treatment algorithm for hepatocellular carcinoma.

KW - Evidence-based medicine

KW - Hepatocellular carcinoma

KW - Management

KW - Randomized controlled trials

UR - http://www.scopus.com/inward/record.url?scp=70449337659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449337659&partnerID=8YFLogxK

U2 - 10.1016/j.soc.2009.09.012

DO - 10.1016/j.soc.2009.09.012

M3 - Article

C2 - 19914564

AN - SCOPUS:70449337659

VL - 19

SP - 151

EP - 162

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

SN - 1055-3207

IS - 1

ER -